Conteltinib (Synonyms: CT-707) |
カタログ番号GC35728 |
コンテルチニブ (CT-707) は、FAK、ALK、および Pyk2 を標的とするマルチキナーゼ阻害剤です。コンテルチニブは、1.6 nM の IC50 で FAK に対して有意な阻害効果を発揮します。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1384860-29-0
Sample solution is provided at 25 µL, 10mM.
Conteltinib (CT-707) is a multi-kinase inhibitor targeting FAK, ALK, and Pyk2. Conteltinib (CT-707) exerts significant inhibitory effect on FAK with an IC50 of 1.6 nM[1]. IC50: 1.6 nM (FAK)[1]
[1]. Wang DD, et al. CT-707, a Novel FAK Inhibitor, Synergizes with Cabozantinib to Suppress Hepatocellular Carcinoma by Blocking Cabozantinib-Induced FAK Activation. Mol Cancer Ther. 2016 Dec;15(12):2916-2925.
Average Rating: 5
(Based on Reviews and 23 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *